Endothelium Aging and Vascular Diseases
نویسندگان
چکیده
Aging is a biological process that causes a progressive deterioration of structure and func‐ tion of all organs over the time [1]. According to the United Nation’s report, the number of people aged 60 and over in the world has increased from 8% (200 million) in 1950 to 11% (760 million) in 2005, and it is estimated that this number will further increase to 22% (2 bil‐ lion) in 2050. It is expected that in the US alone, the aged population of 65 and over will grow rapidly and reach 81 million by 2050 [2,3]. This rapidly increasing aging population will not only cause a decline of productive workforce but also negatively affect the country’s economy. Furthermore, aging is one of the major risk factors for the development of many diseases including cardiovascular diseases [4], stroke [5] and cancer [6]. Moreover, the epi‐ demiological data strongly suggests that more often these diseases are diagnosed in older people compared to younger individuals. In addition to the huge economical impact, these diseases also cause loss of productivity and disability in the elderly population. Therefore, it is extremely important to give high priorities to aging and age-associated disease research in order to develop novel therapies to slow the aging process as well as to prevent and /or treat the age-associated diseases more effectively. It has been found that many factors including genetics [7,8], metabolism [9], diet [10] and stress [11] can in part contribute to the aging process. Similar to other organs, the vascular system, which provides oxygen and nutrients to all the organs in the body, is also affected by the aging process and becomes more vulner‐ able to disease development in the elders [12,13]. For example, vascular diseases such as cor‐ onary artery disease, peripheral arterial disease, stroke and microvascular disease are more often found in the aged population. This is in part due to the structural and functional changes that occur in the vascular system of aged people. In this review, we highlighted (i) the changes that occur in the vascular system, particularly in the endothelium due to aging; (ii) the mechanisms by which the age-associated changes lead to decreased angiogenesis;
منابع مشابه
Vascular Aging and Diseases: Molecular Mechanisms and Influences
Vascular aging plays an important role in the mortality of the elderly, but vascular aging can be dependent on other factors such as diseases. Various diseases such as Alzheimer, diabetes, thalassemia, and other diseases affect the mechanisms of vascular aging. It will harm the recovery process of these patients. There are methods for measuring vascular aging such as instrumental measurements a...
متن کاملEndothelium-Dependent Attenuating Effect of Trigonella foenum-graecum on the Contractile Vascular Reactivity of Diabetic Rats
The present study was undertaken to determine whether two-month treatment of streptozotocin (STZ)-diabetic rats with aqueous leaf extract of Trigonella foenum-graecum (TFG 200 mg/kg i.p.) could improve thoracic aortic responsiveness and to evaluate its endothelium dependency. For this purpose, vascular responses to KCl and noradrenaline (NA) were measured. Diabetic state significantly increased...
متن کاملAging-Shifted Prostaglandin Profile in Endothelium as a Factor in Cardiovascular Disorders
Age-associated endothelium dysfunction is a major risk factor for the development of cardiovascular diseases. Endothelium-synthesized prostaglandins and thromboxane are local hormones, which mediate vasodilation and vasoconstriction and critically maintain vascular homeostasis. Accumulating evidence indicates that the age-related changes in endothelial eicosanoids contribute to decline in endot...
متن کاملRelaxatory Effect of Gamma-Aminobutyric Acid (GABA) is Mediated by Same Pathway in Diabetic and Normal Rat Mesenteric Bed vessel
Objective(s) Diabetes related dysfunction of resistance vessels is associated with vascular occlusive diseases. Vasorelaxant agents may have a role in control of diabetic cardiovascular complications. Gamma aminobutyric acid (GABA) has demonstrated to cause vasorelaxation. The present study was designed to determine i) the vasorelaxatory effect of GABA on diabetic vessels and ii) the role of e...
متن کاملNitric oxide and the bioactivities
Nitric oxide (NO), previously known as Endothelium-Derived Relaxing Factor (EDRF) is involved in a wide range of physiological and pathophysiological mechanisms. It is synthesized endogenously by the enzymes Nitric Oxide Synthase (NOS) in specialized tissues from its precursor L-arginine, yielding L-citrulline as a byproduct. It is released by a family of isoenzymes, viz., the endothelial (eNOS...
متن کاملNitric oxide and the bioactivities
Nitric oxide (NO), previously known as Endothelium-Derived Relaxing Factor (EDRF) is involved in a wide range of physiological and pathophysiological mechanisms. It is synthesized endogenously by the enzymes Nitric Oxide Synthase (NOS) in specialized tissues from its precursor L-arginine, yielding L-citrulline as a byproduct. It is released by a family of isoenzymes, viz., the endothelial (eNOS...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017